Baxter Healthcare recalled 15,552 IV extension sets on August 29, 2025, due to a leak risk. The recall affects products distributed nationwide across 50 states. Healthcare providers and patients must stop using the devices immediately.
IV sets may leak.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Baxter Healthcare Corporation or your healthcare provider for instructions
The recalled product is the CLEARLINK SYSTEM EXTENSION SET with product code 2C8610. These IV extension sets measure 44 inches and feature a Luer activated valve and retractable collar. They were distributed nationwide in the United States.
The IV extension sets may leak, posing a significant risk to patients. This issue falls under Class II recall, indicating a moderate risk of injury.
There have been no specific reports of injuries or incidents mentioned related to the recalled IV extension sets. However, the potential for leakage raises serious concerns.
Stop using the recalled IV extension sets immediately. Patients and healthcare providers should follow the recall instructions provided by Baxter Healthcare Corporation.
For further information, contact Baxter Healthcare Corporation or your healthcare provider. More details about the recall can be found at the FDA website.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.